{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:05:04Z","timestamp":1769079904615,"version":"3.49.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":679,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Recurrent heart failure hospitalization (HFH) is an important feature of the progression of heart failure (HF). In the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, we analysed risk factors for recurrent HFH events in HF patients with preserved ejection fraction (HFpEF) and developed a risk prediction model for recurrent HFH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This analysis focused on the subset of TOPCAT participants enrolled in the Americas (n = 1767). Recurrent HFH was defined as two or more hospitalizations for HF during the follow-up period. Lasso regression and multivariate logistic regression were used to screen the risk factors, and the risk prediction model of recurrent HFH was established. During a median follow-up period of 3.4 (95% confidence interval: 3.3\u20133.6) years, 72.2% (542 of 751 total hospitalizations) of HFH events occurred in 9.4% (n = 163) of patients with recurrent HFHs. Patients in the recurrent HFH group had higher cardiovascular mortality rate [6.2 per 100 patient-years (PY) vs. 3.8 per 100 PY, P = 0.016] and all-cause mortality rate (10.0 per 100 PY vs. 6.8 per 100 PY, P = 0.015) than those in the non-recurrent HFH group. The model consisting of nine predictors has moderate predictive power for recurrent HFH events in patients with HFpEF (AUC = 0.75, Brier score = 0.08). Decision curve analysis showed a net clinical benefit from the application of the prediction model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with HFpEF, the majority of HFHs occur in a small proportion of patients with repeated hospitalizations, who typically have more comorbidities and are at higher risk of death. The predictive model developed in this study helps to identify patients at high risk of recurrent HFH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14570","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T03:59:10Z","timestamp":1701835150000},"page":"475-482","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent Heart Failure Hospitalizations in Heart Failure with Preserved Ejection Fraction: An Analysis of TOPCAT Trial"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2186-8496","authenticated-orcid":false,"given":"Qi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiquan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Echocardiography, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"2026012113074543400_ehf214570-bib-0001","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2012.09.038","article-title":"Rehospitalization for heart failure: Problems and perspectives","volume":"61","author":"Gheorghiade","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012113074543400_ehf214570-bib-0002","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1002\/ehf2.12792","article-title":"Recurrent hospitalizations are associated with increased mortality across the ejection fraction range in heart failure","volume":"7","author":"Huusko","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012113074543400_ehf214570-bib-0003","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jacc.2019.11.003","article-title":"Prior heart failure hospitalization, clinical outcomes, and response to sacubitril\/valsartan compared with valsartan in HFpEF","volume":"75","author":"Vaduganathan","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026012113074543400_ehf214570-bib-0004","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Rehospitalizations among patients in the Medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N Engl J Med"},{"key":"2026012113074543400_ehf214570-bib-0005","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1007\/s12325-020-01456-1","article-title":"Clinical and economic burden of chronic heart failure and reduced ejection fraction following a worsening heart failure event","volume":"37","author":"Butler","year":"2020","journal-title":"Adv Ther"},{"key":"2026012113074543400_ehf214570-bib-0006","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jhealeco.2019.02.002","article-title":"The effect of predictive analytics-driven interventions on healthcare utilization","volume":"64","author":"David","year":"2019","journal-title":"J Health Econ"},{"key":"2026012113074543400_ehf214570-bib-0007","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/eurheartj\/ehs277","article-title":"Time to move on from \u2018time-to-first\u2019: should all events be included in the analysis of clinical trials?","volume":"33","author":"Anker","year":"2012","journal-title":"Eur Heart J"},{"key":"2026012113074543400_ehf214570-bib-0008","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jamacardio.2023.0711","article-title":"Effect of dapagliflozin on total heart failure events in patients with heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the DELIVER trial","volume":"8","author":"Jhund","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026012113074543400_ehf214570-bib-0009","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012113074543400_ehf214570-bib-0010","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"2026012113074543400_ehf214570-bib-0011","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jamacardio.2020.6455","article-title":"Clinical outcomes and response to Vericiguat according to index heart failure event: Insights from the VICTORIA trial","volume":"6","author":"Lam","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026012113074543400_ehf214570-bib-0012","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1161\/CIRCHEARTFAILURE.113.001281","article-title":"Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction","volume":"7","author":"Bello","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026012113074543400_ehf214570-bib-0013","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.mayocp.2019.01.017","article-title":"Clinical and socioeconomic predictors of heart failure readmissions: A review of contemporary literature","volume":"94","author":"Su","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"2026012113074543400_ehf214570-bib-0014","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ejhf.2417","article-title":"A population-based study of 92 clinically recognized risk factors for heart failure: Co-occurrence, prognosis and preventive potential","volume":"24","author":"Banerjee","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026012113074543400_ehf214570-bib-0015","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/ejhf.2134","article-title":"Serum potassium and outcomes in heart failure with preserved ejection fraction: A post-hoc analysis of the PARAGON-HF trial","volume":"23","author":"Ferreira","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026012113074543400_ehf214570-bib-0016","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004137","article-title":"Mortality risk among heart failure patients with depression: A nationwide population-based cohort study","volume":"5","author":"Adelborg","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026012113074543400_ehf214570-bib-0017","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/ejhf.162","article-title":"Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: Findings from 14,713 patients in the Swedish heart failure registry","volume":"16","author":"Lund","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012113074543400_ehf214570-bib-0018","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012113074543400_ehf214570-bib-0019","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1093\/eurheartj\/ehad344","article-title":"Sacubitril\/valsartan in heart failure with mildly reduced or preserved ejection fraction: A pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF","volume":"44","author":"Vaduganathan","year":"2023","journal-title":"Eur Heart J"},{"key":"2026012113074543400_ehf214570-bib-0020","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026012113074543400_ehf214570-bib-0021","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026012113074543400_ehf214570-bib-0022","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle heart failure model: Prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"2026012113074543400_ehf214570-bib-0023","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/ejhf.32","article-title":"Predicting survival in heart failure: Validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registry","volume":"16","author":"Sartipy","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012113074543400_ehf214570-bib-0024","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/archinte.168.13.1371","article-title":"Statistical models and patient predictors of readmission for heart failure: A systematic review","volume":"168","author":"Ross","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026012113074543400_ehf214570-bib-0025","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.pcad.2015.09.004","article-title":"The prevention of hospital readmissions in heart failure","volume":"58","author":"Ziaeian","year":"2016","journal-title":"Prog Cardiovasc Dis"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/1\/475\/64509040\/eschf_11_1_475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/1\/475\/64509040\/eschf_11_1_475.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:08:17Z","timestamp":1769018897000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/1\/475\/8268240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,6]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14570","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,12,6]]},"assertion":[{"value":"2023-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}